Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022

Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
  • Park, Seon Kyeong; 
  • Choe, Young June; 
  • Jang, Eun Jung; 
  • Kim, Ryu Kyung; 
  • Lee, Sang-Won; 
  • 외 5명
Citations

WEB OF SCIENCE

2
Citations

SCOPUS

3

초록

We conducted a cohort study to assess vaccine effectiveness (VE) of coronavirus disease 2019 vaccine combinations on severe acute respiratory syndrome coronavirus 2 critical infection and death among elderly population in Korea. From January to August 2022, VE against death for 4 doses mRNA recipients was 96.1%, whereas 1-dose viral vector + 3-dose mRNA recipients had VE of 90.8%.

키워드

COVID-19; SARS-CoV-2; Coronavirus; Elderly
제목
Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
제목 (타언어)
Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
저자
Park, Seon Kyeong; Choe, Young June; Jang, Eun Jung; Kim, Ryu Kyung; Lee, Sang-Won; Kwon, Geun-Yong; Shin, Jeeyeon; Choi, Sang-Yoon; Jeong, Mi Jin; Park, Young-Joon
DOI
10.3346/jkms.2023.38.e143
발행일
2023-05
유형
Article
저널명
Journal of Korean Medical Science
권
38
호
19
페이지
1 ~ 5